Meropenem Kalceks

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and sepsis in hospitalized patients.

GNH USA supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: eradicates the causative Gram‑negative and anaerobic bacteria, leading to clinical resolution. Complicated urinary tract infections: eliminates resistant uropathogens and restores urinary sterility. Nosocomial pneumonia: provides rapid bacterial clearance in hospital‑acquired lung infections. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. Severe sepsis and septic shock: offers broad coverage to control systemic infection and improve hemodynamic stability.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional episodes during infusion. - Rash: transient skin erythema. - Headache: mild, often resolves after treatment. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: acute hypersensitivity reaction requiring immediate intervention. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hepatic failure: rare but potentially life‑threatening liver dysfunction.

Meropenem should be used with caution in specific clinical situations.

Renal function: adjust dose in patients with impaired renal clearance. Allergy: avoid in individuals with known hypersensitivity to carbapenems or beta‑lactams. Seizure risk: monitor closely in patients with a history of seizures or CNS disorders. Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. Concurrent antibiotics: assess for antagonistic effects when combined with bacteriostatic agents. Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake the solution.

Meropenem may interact with several medications that alter its efficacy or safety.

Major Interactions (Avoid): - Valproic acid: reduces plasma levels, risking loss of seizure control. - Probenecid: decreases renal clearance, increasing meropenem exposure. - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Aminoglycosides: additive nephrotoxicity, especially in renal impairment. - Other carbapenems: potential antagonism when used together.

Moderate Interactions (Monitor Closely): - Diuretics: electrolyte shifts may affect drug distribution. - Antiepileptics: may lower seizure threshold, requiring vigilance. - Oral contraceptives: possible reduction in efficacy, advise alternative contraception.